Brief: Prostatype Genomics H2 EBITDA Loss Widens To SEK 17.8 Mln
Feb 15 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* H2 NET SALES AMOUNTED TO 908 TSEK (414)
* H2 EBITDA -17,797 TSEK (-14,849)
Source text for Eikon: ID:nWkr7ZbtxN
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue